Tag: Marketing & Sales

Posted on by — Leave a comment

Asthma Clinical Trials Analysis 2024: Therapies, FDA Approvals, Mechanism of Action, Route of Administration, and Companies by DelveInsight

Asthma Clinical Trials Asthma companies are Mabpharm Limited, GlaxoSmithKline, Immunotek SL, AB Science, AstraZeneca, Inmunotek, Sterna Biologics, Verona Pharma, MediciNova, Foresee Pharmaceuticals, T-Balance Therapeutics, Teva Pharmaceutical, AstraZeneca, Cumberland Pharmaceuticals, Concentrx Pharmaceuticals, Sanofi, Oneness Biotech, Novartis, Keymed Biosciences, Suzhou Connect Biopharmaceuticals, 4D Pharma Plc, Hoffman-La-Roche, Celltrion, Glenmark Pharmaceuticals, Archivel Farma, Siolta Therapeutics, and others. (Albany, USA) […]

Posted on by — Leave a comment

AL Amyloidosis Pipeline Assessment 2024: Therapies, Clinical Trials, by DelveInsight | Sorrento Therapeutics, Prothena Therapeutics, Spectrum Pharma, Takeda, Millennium Pharma, Caelum Biosciences

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, AL Amyloidosis pipeline constitutes 10+ key companies continuously working towards developing 10+ AL Amyloidosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “AL Amyloidosis Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present […]

Posted on by — Leave a comment

Mesothelioma Pipeline Dynamics 2024: FDA Approvals, Therapeutic Advances, by DelveInsight | GSK, Merck, Bristol-Myers Squibb, AstraZeneca, Roche, Novartis, Pfizer Inc., Eli Lilly and Company, J&J

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Mesothelioma pipeline constitutes 45+ key companies continuously working towards developing 50+ Mesothelioma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Mesothelioma Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario […]

Posted on by — Leave a comment

Encephalopathy Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight

Encephalopathy Pipeline Encephalopathy companies are Xenon Pharmaceuticals, Rebiotix, Axcella Health, Neurocrine Biosciences, Takeda, Praxis Precision Medicines, Stoke Therapeutics, Longboard Pharmaceuticals, Knoop Biosciences, Praxis Precision Medicine, Q-State Biosciences, Inc, Ocera Therapeutics, and others. (Las Vegas, Nevada, United States)  As per DelveInsight’s assessment, globally, Encephalopathy pipeline constitutes 70+ key companies continuously working towards developing 70+ Encephalopathy treatment […]

Posted on by — Leave a comment

HER2-Positive Breast Cancer Pipeline Update 2024: FDA Approvals, Therapeutic Advancements by DelveInsight | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx, Alteogen, Suzhou Zanrong Pharm

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, HER2-Positive Breast Cancer pipeline constitutes 60+ key companies continuously working towards developing 65+ HER2-Positive Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “HER2-Positive Breast Cancer Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights […]

Posted on by — Leave a comment

Congenital Hyperinsulinism Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Clinical Trials by DelveInsight | Zealand Pharma, Rezolute, Hanmi Pharma, Crinetics Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Congenital Hyperinsulinism pipeline constitutes 4+ key companies continuously working towards developing 6+ Congenital Hyperinsulinism treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Congenital Hyperinsulinism Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present […]

Posted on by — Leave a comment

Tinnitus Pipeline Assessment, 2024 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, & Treatment Outlook | Bayer, Takeda Pharma, Pfizer, Sanofi

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Tinnitus pipeline constitutes 7+ key companies continuously working towards developing 8+ Tinnitus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Tinnitus Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario […]

Posted on by — Leave a comment

Tendinopathy Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Novartis, ZARS Pharma Inc., Merck Sharp, Erasmus Medical Center, CTM Biomedical

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Tendinopathy pipeline constitutes 5+ key companies continuously working towards developing 5+ Tendinopathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Tendinopathy Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario […]

Posted on by — Leave a comment

Dysthymia Market Forecast 2032: Clinical Trials, Epidemiology, FDA Approvals, Therapies, and Companies by DelveInsight

Dysthymia Market Dysthymia companies are AbbVie, Novartis International AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Sanofi S.A., Merck & Co, Columbia Northwest Pharmaceuticals, Otsuka Pharmaceuticals Co., Ltd., Allergan Inc., GlaxoSmithKline plc, Eli Lilly and Company, Bayer AG, and others. (Albany, USA) DelveInsight’s “Dysthymia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of […]

Posted on by — Leave a comment

Arteriovenous Malformations Market on Track for Major Expansion by 2032, According to DelveInsight | Genentech, Micro Therapeutics Inc., Shire, Eisai Co., Ltd., Merck Sharp & Dohme LLC, Proteon

The Arteriovenous Malformations Market Forecast report offers an in-depth understanding of the Arteriovenous Malformations, historical and forecasted epidemiology as well as the Arteriovenous Malformations market trends in the 7MM. DelveInsight’s “Arteriovenous Malformations Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Arteriovenous Malformations, historical and forecasted epidemiology as well as the […]